Clinical impacts of inflammatory markers and clinical factors in patients with relapsed or refractory diffuse large B-cell lymphoma

BACKGROUND: Systemic inflammatory response can be associated with the prognosis of diffuse large B cell lymphoma (DLBCL). We investigated the systemic factors significantly related to clinical outcome in relapsed/refractory DLBCL. METHODS: In 242 patients with DLBCL, several factors, including infla...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Blood Res
Autors principals: Kim, Do-Young, Song, Moo-Kon, Chung, Joo-Seop, Shin, Ho-Jin, Yang, Deok Hwan, Lim, Sung-Nam, Oh, Sung-Yong
Format: Artigo
Idioma:Inglês
Publicat: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2019
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6942137/
https://ncbi.nlm.nih.gov/pubmed/31915650
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5045/br.2019.54.4.244
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars